Preliminary report on the effect of etoposide or etoposide and CDDP on recurrent prostate cancer

Eight patients with recurrent prostate cancer were treated with Etoposide and CDDP or Etoposide alone. Etoposide was administered at a dose of 20 approximately 50 mg/m2/day for 5 consecutive days and CDDP was administered at a dose of 30 approximately 50 mg/m2 on the first day. Treatment was repeate...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 37(1991), 11 vom: 25. Nov., Seite 1499-503
Auteur principal: Suzuki, K (Auteur)
Autres auteurs: Nakamura, T, Kato, N, Kurita, M, Nakazawa, Y, Suzuki, T, Imai, K, Yamanaka, H
Format: Article
Langue:Japanese
Publié: 1991
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:English Abstract Journal Article Etoposide 6PLQ3CP4P3 Cisplatin Q20Q21Q62J